 BURLINGTON, Mass., Nov. 02, 2022 GLOBE NEWSWIRE -- Minerva Neurosciences, Inc. Nasdaq: NERV, a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system CNS disorders, today announced that it will release financial results and business updates for the third quarter of 2022 on Wednesday, November 9, 2022. The Company will host a webcast that day at 8:30 a.m. Eastern Time to discuss the results and updates. 